| Product Code: ETC6955214 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Denmark continues to rely on key exporters such as Spain, USA, Belgium, Germany, and UK for its carcinoembryonic antigen imports in 2024. Despite a high concentration in the market, the compound annual growth rate (CAGR) from 2020 to 2024 was significant at 29.58%, indicating a growing demand for this product. However, there was a notable decline in the growth rate from 2023 to 2024 at -37.88%, suggesting a potential shift or temporary setback in the market dynamics. Monitoring these trends will be crucial for stakeholders in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Denmark Carcinoembryonic Antigen Market Overview |
3.1 Denmark Country Macro Economic Indicators |
3.2 Denmark Carcinoembryonic Antigen Market Revenues & Volume, 2021 & 2031F |
3.3 Denmark Carcinoembryonic Antigen Market - Industry Life Cycle |
3.4 Denmark Carcinoembryonic Antigen Market - Porter's Five Forces |
3.5 Denmark Carcinoembryonic Antigen Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Denmark Carcinoembryonic Antigen Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Denmark |
4.2.2 Growing awareness about early cancer detection and screening |
4.2.3 Technological advancements in diagnostic procedures |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for product approval |
4.3.2 High cost associated with diagnostic tests |
4.3.3 Limited reimbursement policies for CEA testing |
5 Denmark Carcinoembryonic Antigen Market Trends |
6 Denmark Carcinoembryonic Antigen Market, By Types |
6.1 Denmark Carcinoembryonic Antigen Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Denmark Carcinoembryonic Antigen Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Denmark Carcinoembryonic Antigen Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.4 Denmark Carcinoembryonic Antigen Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.1.5 Denmark Carcinoembryonic Antigen Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F |
6.1.6 Denmark Carcinoembryonic Antigen Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.7 Denmark Carcinoembryonic Antigen Market Revenues & Volume, By Thyroid Cancer, 2021- 2031F |
6.1.8 Denmark Carcinoembryonic Antigen Market Revenues & Volume, By Others, 2021- 2031F |
7 Denmark Carcinoembryonic Antigen Market Import-Export Trade Statistics |
7.1 Denmark Carcinoembryonic Antigen Market Export to Major Countries |
7.2 Denmark Carcinoembryonic Antigen Market Imports from Major Countries |
8 Denmark Carcinoembryonic Antigen Market Key Performance Indicators |
8.1 Adoption rate of CEA testing in Denmark |
8.2 Number of research studies and publications highlighting the importance of CEA testing |
8.3 Investment in RD for developing innovative CEA testing technologies |
9 Denmark Carcinoembryonic Antigen Market - Opportunity Assessment |
9.1 Denmark Carcinoembryonic Antigen Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Denmark Carcinoembryonic Antigen Market - Competitive Landscape |
10.1 Denmark Carcinoembryonic Antigen Market Revenue Share, By Companies, 2024 |
10.2 Denmark Carcinoembryonic Antigen Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |